Smak Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Bangalore, Karnataka, India, established in 1985.
1985 Bangalore, Karnataka, India Struck Off
Last Updated:
Access Report
About Smak Pharmaceuticals Private Limited

Smak Pharmaceuticals Private Limited, a struck off private limited company, was established on 20 November 1985 in Bangalore, Karnataka, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230KA1985PTC007296. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.70 M and a paid-up capital of ₹1.63 M.

Its leadership includes Nanjundaiah Nanjappa Beladhara (Managing Director), Kasturi Nanjundaiah (Director). Its latest AGM occurred on 29 September 2010, with the balance sheet filed on 31 March 2010. It is based at Thrishathi, 180, 11Th Cross, 3Rd Main Bda Hig, Rmv 2Nd Stage, Bangalore, Karnataka, 560094.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KA1985PTC007296

  • Registration Number

    007296

  • Incorporation Date

    20 November 1985

  • Authorized Capital

    ₹1.70 M

  • Paid-Up Capital

    ₹1.63 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.70 M
  • Paid Up Capital ₹ 1.63 M
  • Company Age 40 Year, 6 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Smak Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Smak Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Smak Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nanjundaiah Nanjappa Beladhara Managing Director 14 Jun 2006 Current
Kasturi Nanjundaiah Director 14 Jun 2006 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Smak Pharmaceuticals.

Enhance accessibility to Smak Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Smak Pharmaceuticals revenue growth over time
Smak Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Smak Pharmaceuticals?

Unlock access to Smak Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Smak Pharmaceuticals?

Unlock and access historical data on people associated with Smak Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Smak Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smak Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Smak Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Smak Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2010 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Smak Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Bangalore. was documented.

  • Director Appointment

    Nanjundaiah Nanjappa Beladhara was appointed as a Managing Director was appointed as a Managing Director on 14 Jun 2006 & has been associated with this company since 19 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Kasturi Nanjundaiah was appointed as a Director was appointed as a Director on 14 Jun 2006 & has been associated with this company since 19 years 11 months . was completed.

  • Company Incorporation

    Smak Pharmaceuticals Private Limited was registered on 20 Nov 1985 with Roc Bangalore & aged 40 years 6 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Smak Pharmaceuticals Private Limited?

The CIN of Smak Pharmaceuticals Private Limited is U24230KA1985PTC007296.

Where is Smak Pharmaceuticals Private Limited headquartered?

Smak Pharmaceuticals Private Limited is headquartered at Thrishathi, 180, 11Th Cross, 3Rd Main Bda Hig, Rmv 2Nd Stage, Bangalore, Karnataka, 560094.

When was Smak Pharmaceuticals Private Limited incorporated?

Smak Pharmaceuticals Private Limited was incorporated on 20 November 1985.

Who are the current directors of Smak Pharmaceuticals Private Limited?

The current directors of Smak Pharmaceuticals Private Limited are

What is the primary industry of Smak Pharmaceuticals Private Limited?

The primary industry of Smak Pharmaceuticals Private Limited is Chemicals.

Is Smak Pharmaceuticals Private Limited a listed company?

Smak Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Smak Pharmaceuticals Private Limited?

The authorized capital of Smak Pharmaceuticals Private Limited is ₹1.70 M, and the paid-up capital is ₹1.63 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available